Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SKW02 is a biological therapeutic candidate developed by Skye Biologics, designed for regenerative medicine applications in orthopedics. It is specifically indicated for use in rotator cuff repair and the treatment of Achilles proximal tendon tears. As part of Skye Biologics' second-generation biological therapeutics, SKW02 utilizes naturally advanced human biological materials to facilitate tissue repair and promote healing in damaged musculoskeletal structures. The product is intended to enhance surgical outcomes and support functional recovery by leveraging the regenerative properties of human-derived biologics, although its specific molecular composition and targets remain proprietary.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SKW02.